retatrutide dosering Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Starting Dose - small

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

Retatrutide is distinctive because it activates three metabolic hormone receptors: GLP-1R, GIPR, and GCGR, within a single peptide structure

When added together, the effects may lead to worse nausea, vomiting, or unexpected changes in blood sugar

For those ordering from Canadian peptide suppliers like Red Fox Peptides, vials typically come in 5 mg or 10 mg sizes for both compounds

Double-check your math before every draw

This probiotic is Doctor-Formulated specifically for your needs, providing double-action support to help you feel better